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Volume 59, Number 6S Abstracts 29SObjectives: This study evaluates the feasibility, safety,
and effectiveness of endovascular interventions for com-
mon femoral artery (CFA) occlusive disease.
Methods: Using a prospectively maintained multi-
center database, we analyzed outcomes in 167 consecutive
patients who underwent percutaneous CFA interventions
for Rutherford (R) 3 to R6 classiﬁcation. The standardized
treatment approach included primary PTA-only for noncal-
ciﬁed lesions with <50% residual stenosis, atherectomy
with or without PTA for calciﬁed lesions or PTA-only fail-
ures, and provisional stenting.
Results: Over a 7-year period, 167 patients with R3 (n
¼ 91 [54.5%]), R4 (n ¼ 37 [22.2%]) or R5-6 (n ¼ 39
[23.4%]) underwent isolated CFA interventions that
included PTA-only (n ¼ 114 [68.2%]), atherectomy with
or without PTA (n ¼ 38 [22.8%]), or stent (n ¼ 15
[9.0%]) for failed atherectomy with or without PTA. Proce-
dure-related complications included pseudoaneurysm (n ¼
1 [0.6%]), thrombosis (n ¼ 1 [0.6%]), distal embolization
(n ¼ 1 [0.6%]), and death (R6, n ¼ 1 [0.06%]). At
a mean follow-up of 17 months, CFA restenosis was
observed in 29 patents (17.4%); these underwent further
percutaneous (n ¼ 13 [7.8%]) or surgical (n ¼ 16 [9.6%])
revascularization that included femoral endarterectomy
(n ¼ 4 [2.4%]) or femoral-popliteal/tibial bypass (n ¼ 12
[7.2%]). Major or minor amputations were observed in
none of the R3 patients, and in only three (3.9%) and ﬁve
(6.6%) of the R4 to R6 patients, respectively. When
compared with the atherectomy with or without PTA
group, patients in the PTA-only group had a signiﬁcantly
higher incidence of female gender (43% vs 24%), diabetes
(49% vs 29%), hypertension (89% vs 76%), and restenosis
requiring secondary interventions (21.9% vs 5.3%; P< .01).
Conclusions: Data from this largest study to date
would suggest that percutaneous CFA interventions in
select patients appear to be relatively safe and effective. Fe-
male gender, diabetes, and hypertension negatively impact
risk of restenosis, whereas atherectomy with or without
PTA reduces re-stenosis risks signiﬁcantly. A randomized
controlled trial is warranted.
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A Randomized Controlled Trial of Domain-Speciﬁc
Cognitive Function After Carotid Endarterectomy
and Stenting
Panos Kougias1, Nicholas Pastorek1, Robert Collins1, Sally
A. McCoy2, Sherene Sharath2, Briauna Lowery2, Shalinie
Mukhi2, Katie McCulloch3, Carlos Bechara1, Neal
Barshes1, George Pisimisis1, David Berger1. 1BaylorCollege of Medicine, Houston, Tex; 2Michael E.
DeBakey VAMC, Houston, Tex; 3University of Houston,
Houston, Tex
Objectives: Observational data indicate that carotid
artery stenting (CAS) is associated with higher incidence
of subclinical cerebral microemboli than carotid endarter-
ectomy (CEA). We hypothesized that CEA would be asso-
ciated with superior performance on cognitive domain-
speciﬁc testing compared with CAS.
Methods: Patients with >80% asymptomatic carotid ar-
tery stenosis were randomized to CEA or CAS. A robust bat-
tery of tests was used to assess the cognitive domains of
attention, memory, mood, visual-spatial skills, motor ability,
processing speed, and executive functioning #10 days preop-
eratively and at 6 weeks and 6 months postoperatively. Patients
without contraindications to magnetic resonance imaging un-
derwent assessment of cerebral microinfarcts (CMI), mean
transit time (MTT), cerebral blood ﬂow (CBF), and cerebral
blood volume (CBV) at the same time points.
Results: Baseline cognitive performance was similar be-
tween CAS (n ¼ 29) and CEA (n ¼ 31) groups (P > .05).
Relative to baseline, verbal and visual memory and attention
functions improved in CAS and CEA groups at 6 months
(multiple cognitive tests achieved statistical signiﬁcance).
Compared with CEA, cognitive processing speed (Stroop
Color test: 9.0 vs 7.3, P ¼ .04; and Stroop Word test: 9.0
vs 7.4, P ¼ .05) and executive functioning (Trail Making
Test: 49.4 vs 44, P ¼ .06) were superior in CAS at 6 weeks.
Executive functioning (Phonemic verbal ﬂuency: 10.6 vs
8.4, P ¼ .01) and motor function (Grooved Pegboard of
nondominant extremity: 45.7 vs 38.9, P ¼ .01) were also
superior in CAS at 6 months. Tests of attention, memory,
and visual-spatial skills were similar between CAS and
CEA at 6 weeks and 6 months. CMI, CBV, CBF, and
MTT were similar between the groups at all time points.
Conclusions: Memory and attention improve within
the ﬁrst 6 postoperative months with both CAS and
CEA. Compared with CEA, CAS results in improved
cognitive processing speed, executive functioning, and mo-
tor function.
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Objectives: Rapid and objective preoperative assess-
ment of patients undergoing carotid endarterectomy
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increased morbidity and mortality, yet no easily imple-
mented tool exists to stratify patients. We determined the
relationship between our fully implemented frailty-based
bedside Risk Analysis Index (RAI) and complications after
carotid endarterectomy (CEA).
Methods: Variables of frailty RAI for patients under-
going CEA in American College of Surgeons National Sur-
gical Quality Improvement Project (NSQIP) database
(2005-2011) were matched to preoperative NSQIP vari-
ables, and outcomes including mortality, stroke, and length
of stay were analyzed. We further analyzed patients who
were symptomatic and asymptomatic before CEA.
Results: A total of 44,832 patients undergoing CEA
were analyzed, of which 27,136 (60.5%) were asymptomatic
and 17,696 (39.5%) were symptomatic. RAI demonstrated
increasing risk of stroke anddeath based on risk stratiﬁcation:
low risk (0-10), 1.9%; high risk (>10), 5.2%. Increasing
frailty RAI score correlatedwith increasingmortality, stroke,
and length of stay (P< .01; Fig). Themajority of patients un-
dergoingCEA scored low on the RAI (87.5% symptomatic/
94.4% asymptomatic).
Conclusions: Frailty is an independent predictor of
increased mortality, stroke, and length of stay after CEA.
An easily implemented RAI holds the potential to identify
a limited subset of patients who are at higher risk for post-
operative complications and may not beneﬁt from CEA.
Fig. Stroke and death rate for total NSQIP CEA group based on
frailty RAI score.
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Anatomical Exposure of Thoracic Outlet With
Supraclavicular Approach and Resection of Cervical Rib
Himanshu Verma, Ramesh K. Tripathi. Narayana Institue
of Vascular Sciences, Narayana Hrudayalaya, Bangalore,
IndiaBackground: Thoracic outlet syndrome is known for
complex anatomy of this region. The scalene triangle is a
narrow space with neurovascular bundle emerging from it
with multiple anatomical variations described. Depending
on the requirement, rib resection (cervical, ﬁrst, or both),
scalenectomy, and various degrees of neurolysis are per-
formed in different patients. Various approaches had been
described for this anatomical region, including supraclavic-
ular, paraclavicular. and transaxillary.
Technical description: This patient had sign symp-
toms consistent with arterial and neurogenic thoracic
outlet syndrome. Preoperative computed tomography
showed a complete right cervical rib causing arterial and
neural compression. The video view has been adjusted as
per view to the main operator standing on right side of pa-
tient. The operation was performed in following steps: (1)
supraclavicular incision; (2) raising superior and inferior
subplatysmal ﬂaps; (3) dissection of scalene pad of fat; (4)
dissection of phrenic nerve; (5) anterior scalenectomy;
(6) dissection of subclavian artery, neurolysis including
resection of multiple muscle slips interdigitating between
brachial plexus; (7) resection of cervical rib; (8) hemostasis
and wound closure. In our experience 42 thoracic outlet
syndrome decompressions have been performed between
January 2011 and September 2013 (18 arterial, 12 arterial
and neurologic, 8 neurologic and venous, and 4 venous
thoracic outlet syndromes). In 25 cases, the supraclavicular
approach was used, whereas 17 cases involved paraclavicu-
lar approach. There was 7% perioperative morbidity with
no mortality. Although operative steps are familiar for
most surgeons who regularly participate in this surgery, a
video demonstration would be useful for trainees to under-
stand the principles of the operation.
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The Effect of Beta Blockade on Operative Mortality:
Harmful or Helpful?
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Objectives: The use of perioperative pharmacologic b-
blockade (BB) in patients with low risk of myocardial
ischemic events undergoing non-cardiac surgery (NCS) is
controversial because of the risk of stroke and hypotension.
Published studies have not shown consistent beneﬁt in this
cohort. The present investigation was undertaken to deter-
mine the perioperative effect of BB on NCS patients.
Methods: This is a retrospectiveobservational analysis of
operative patients in Veterans Affairs (VA) hospitals from
October 2009 through September 2013. BB was started 8
hours before surgery and continued postoperatively. Data
from the VA electronic database included demographics,
diagnosis and procedure codes, medications, perioperative
laboratory values, and date of death. A 4-point cardiac risk
scorewas calculated by assigning1 point each for renal failure,
coronary disease, diabetes, and surgery in amajor body cavity.
End points were death in-hospital and #30 days. Previously
validated linear regression models for all hospitalized acute
